title: Lymphoma cell-of-origin assignment by gene expression profiling is clinically meaningful across broad laboratory contexts.
authors.affiliation: Northern Blood Research Centre, Kolling Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.|Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.
authors.forename: Grace
authors.initials: G
authors.lastname: Gifford
authors.affiliation: Northern Blood Research Centre, Kolling Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
authors.forename: Sara
authors.initials: S
authors.lastname: Gabrielli
authors.affiliation: Department of Anatomical Pathology, Royal North Shore Hospital, Sydney, New South Wales, Australia.|Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
authors.forename: Anthony
authors.initials: A
authors.lastname: Gill
authors.affiliation: Northern Blood Research Centre, Kolling Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.|Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.
authors.forename: Matthew
authors.initials: M
authors.lastname: Greenwood
authors.affiliation: Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.
authors.forename: Kelly
authors.initials: K
authors.lastname: Wong
authors.affiliation: Northern Blood Research Centre, Kolling Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
authors.forename: Giles
authors.initials: G
authors.lastname: Best
authors.affiliation: Department of Anatomical Pathology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
authors.forename: David
authors.initials: D
authors.lastname: Nevell
authors.affiliation: Department of Anatomical Pathology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
authors.forename: Kirsty
authors.initials: K
authors.lastname: McIlroy
authors.affiliation: Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.
authors.forename: David
authors.initials: D
authors.lastname: Kliman
authors.affiliation: Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.
authors.forename: Louise
authors.initials: L
authors.lastname: Ilmay-Gillespie
authors.affiliation: Department of Haematology, Gosford Hospital, Gosford, New South Wales, Australia.
authors.forename: Campbell
authors.initials: C
authors.lastname: Tiley
authors.affiliation: Department of Haematology, Gosford Hospital, Gosford, New South Wales, Australia.
authors.forename: Sunaina
authors.initials: S
authors.lastname: Miranda
authors.affiliation: Department of Haematology, Gosford Hospital, Gosford, New South Wales, Australia.
authors.forename: Tasman
authors.initials: T
authors.lastname: Armytage
authors.affiliation: Northern Blood Research Centre, Kolling Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.|Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.
authors.forename: William
authors.initials: W
authors.lastname: Stevenson
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000378:metabolism / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D015996:Survival Rate; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
keywords: gene expression; lymphomas; molecular diagnostics